HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

(2R)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid

HCID 178536763
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1334321-39-9
Standard SMILES
CC(C)(C)OC(=O)N[C@@H](C(=O)O)C12CC3CC(CC(O)(C3)C1)C2
InChIKey
UKCKDSNFBFHSHC-JGCLWBMSSA-N
Molecular formula
C17H27NO5
Average molar mass
325.4 g/mol
Monoisotopic mass
325.18892296

Overview

See other relationships...

Names & identifiers

Preferred name
(2R)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid
IUPAC
(2R)-2-(3-hydroxy-1-adamantyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid
English name
(R)-N-Boc-3-hydroxyadaMantylglycine
Molecular formula
C17H27NO5
Molecular weight
325.4

Names & synonyms

1334321-39-9Boc-3-Hydroxy-1-adamantyl-L-glycine(2R)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid361442-00-4Boc-(R)-2-(3-Hydroxy-1-adamantyl)glycineMFCD16621100(S)-N-Boc-3-hydroxyadamantylglycine(2R)-2-(3-hydroxy-1-adamantyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acidBOC-3-Hydroxy-1-adamantyl-D-GlycineSaxagliptin Impurity 4(R)-N-Boc-2-(3-hydroxyadamant-1-yl)glycineC17H27NO5
Show more names
N-Boc-adamatyl glycineSacagliptin Impurity 21Boc-3-hydroxy-1-adamantyl-glycine(R)-N-Boc-3-hydroxyadaMantylglycine(R)-2-((tert-butoxycarbonyl)amino)-2-(3-hydroxyfundoxane-1-yl)acetic acidTricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-, (αR)-"(a-R)-a--[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-Tricyclo[3.3.1.13,7]decane-1-acetic acid"(alphaR)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.1(3,7)]decane-1-acetic acid
(R)-2-((tert-butoxycarbonyl)amino)-2-((1r,3S,5R,7S)-3-hydroxyadamantan-1-yl)acetic acid(2R)-2-(tert-butoxycarbonylamino)-2-(3-hydroxy-1-adamantyl)acetic acidAKOS015951196AC-24664H85265F307123Tricyclo[3.3.1.13,7]decane-1-acetic acid, |A-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-, (|AR)-

Properties

Computed structural propertiesFilling in

XLogP
2
Topological polar surface area
95.9 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
5
Rotatable bonds
5
Heavy atoms
23
Formal charge
0
Complexity
510

Physicochemical properties

Melting point
280 °C · >280°C (dec.)
Boiling point
497.3 · 497.3±20.0 °C(Predicted)
Density
1.296 · 1.296±0.06 g/cm3(Predicted)
storage temp.
-20 °C · -20°C Freezer
solubility
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka
3.93 · 3.93±0.10(Predicted)
form
Solid
color
White to Off-White
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H315-H319-H335
Precautionary statements
P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501

Chemistry & industry

Applications · 2 items

UsesBoc-3-hydroxy-1-adamantyl-glycine is an impurity of Saxagliptin (S143500), which is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing.

UsesBoc-3-hydroxy-1-adamantyl-glycine is an impurity of Saxagliptin (S143500), which is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1334321-39-9
PubChem CID
53312468